How effective is Fludrocortisone Acetate for Syncope Vasovagal? (a real world drug study)
Summary:
Overall ratings: 3.4/5 Long term ratings: 3.3/5
This is a phase IV clinical study of how effective Fludrocortisone acetate (fludrocortisone acetate) is for Syncope vasovagal and for what kind of people. The study is created by eHealthMe from 7 Fludrocortisone acetate users and is updated continuously.
What is Fludrocortisone acetate?
Fludrocortisone acetate has active ingredients of fludrocortisone acetate. It is often used in hypotension. eHealthMe is studying from 2,859 Fludrocortisone acetate users. Check the latest studies of Fludrocortisone acetate.
What is Syncope vasovagal?
Syncope vasovagal (malfunction in the parts of the nervous system leads to consciousness with an inability to maintain postural tone) is found to be associated with 155 drugs and 451 conditions by eHealthMe. Check the latest studies of Syncope vasovagal.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
7 people are studied for taking Fludrocortisone acetate in Syncope vasovagal
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Fludrocortisone acetate effectiveness for Syncope vasovagal (number of people):
Overall:
- not at all: 1
- somewhat: 1
- moderate: 1
- high: 2
- very high: 2
Long Term:
- not at all: 0
- somewhat: 1
- moderate: 1
- high: 2
- very high: 0
Gender of people who take Fludrocortisone acetate for Syncope vasovagal *:
- female: 85.71 %
- male: 14.29 %
Age of people who take Fludrocortisone acetate for Syncope vasovagal *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 28.57 %
- 20-29: 14.29 %
- 30-39: 14.29 %
- 40-49: 28.57 %
- 50-59: 14.29 %
- 60+: 0.0 %
Who find Fludrocortisone Acetate more effective for Syncope Vasovagal?
Gender of people who take Fludrocortisone acetate for Syncope vasovagal *:
- female: 75 %
- male: 25 %
Age of people who take Fludrocortisone acetate for Syncope vasovagal *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 50 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 50 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Fludrocortisone acetate?
- You can start a phase IV clinical trial to monitor Fludrocortisone acetate safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Fludrocortisone acetate (2,859 reports)
Treatments, associated drugs and conditions:
- Syncope vasovagal (1,561 reports)
How the study uses the data?
The study is based on fludrocortisone acetate (the active ingredients of Fludrocortisone acetate) and Fludrocortisone acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xalatan and Dyskinesia Aggravated for Women aged 60+ - 11 seconds ago
- Avandamet and Chronic Obstructive Pulmonary Disease for Women aged 60+ - 16 seconds ago
- Avandamet and Copd for Women aged 60+ - 17 seconds ago
- Lupron and Deformity for Men aged 60+ - 17 seconds ago
- Avandamet and Chronic Obstructive Airway Disease for Women aged 60+ - 17 seconds ago
- Avandamet and Chronic Obstructive Lung Disease for Women aged 60+ - 17 seconds ago
- Appetite - Increased and drugs of ingredients of oxazepam - 27 seconds ago
- Restasis and Acular drug interactions for women aged 60+ - 52 seconds ago
- Could Chondroitin cause Angina Pectoris Aggravated? - a minute ago
- Septra and Vitamins drug interactions for girls aged 10-19 - a minute ago